1. Home
  2. OLB vs ACXP Comparison

OLB vs ACXP Comparison

Compare OLB & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The OLB Group Inc.

OLB

The OLB Group Inc.

HOLD

Current Price

$0.34

Market Cap

6.6M

Sector

Technology

ML Signal

HOLD

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

HOLD

Current Price

$1.50

Market Cap

6.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLB
ACXP
Founded
1993
2017
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6M
6.9M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
OLB
ACXP
Price
$0.34
$1.50
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$95.50
AVG Volume (30 Days)
142.3K
78.2K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
71.48
N/A
EPS
N/A
N/A
Revenue
$8,676,907.00
N/A
Revenue This Year
$12.19
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$0.29
52 Week High
$1.85
$8.34

Technical Indicators

Market Signals
Indicator
OLB
ACXP
Relative Strength Index (RSI) 29.48 43.91
Support Level $0.31 $1.37
Resistance Level $0.59 $1.75
Average True Range (ATR) 0.02 0.14
MACD -0.00 0.02
Stochastic Oscillator 6.55 39.02

Price Performance

Historical Comparison
OLB
ACXP

About OLB The OLB Group Inc.

The OLB Group Inc is a diversified FinTech company that focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. The company seeks to provide merchants with a wide range-of-products and services through the various online platforms, including financial and transaction processing services. It also has products that provide support for crowdfunding and other capital-raising initiatives. It supplements the online platforms with certain hardware solutions that are integrated with the online platforms. The company has two business segments: Fintech Services, which generates key revenue, and the Bitcoin Mining business segment.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

Share on Social Networks: